News | February 02, 2012

Aria Health First on East Coast to Use Epoch System to Treat Arrhythmias

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D.,

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D., FACC Scott Spielman, M.D., FACC and Bradley Bacik, DO, FACC, are the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System, to perform robotic ablation of heart arrhythmias.

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D., FACC Scott Spielman, M.D., FACC and Bradley Bacik, DO, FACC, are the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System, to perform robotic ablation of heart arrhythmias.

February 2, 2012 — Aria Health, the largest healthcare provider in Northeast Philadelphia and Bucks County, is the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System. This innovative technology allows electrophysiologists to treat many types of cardiac arrhythmias, or heart rhythm disorders, with robotic-driven catheter ablation procedures.

Housed in the heart center at Aria Health’s Torresdale Campus, Epoch offers many advantages over conventional treatment methods, according to Scott Spielman, M.D., FACC, director of Aria’s electrophysiology laboratory.

"Standard catheters used for ablation are fairly stiff, making them difficult to guide and raising the risk of perforating heart tissue,” said Spielman.  “The Epoch system employs a soft, floppy catheter which enables us to complete procedures in a shorter time period with greater safety.”

The new system reduces patient radiation exposure by two-thirds, and is effective for treating ventricular arrhythmias as well as other types of abnormal heart rhythms.

“This allows us to get a catheter tip to sites inside the complex internal anatomy with less force and more precision,” said Roger Marinchak, M.D., FACC, an electrophysiologist at Aria Health.  “This causes less risk of causing perforation injury to structures that one doesn’t want to ablate or hurt."

As the United States population ages, the number of people with atrial fibrillation (AF) - the most common type of serious arrhythmia - will grow, says Aria electrophysiologist Bradley Bacik, DO, FACC. While AF is a chronic condition that cannot be cured, he adds, ablation treatments available at Aria Health can substantially reduce symptoms.

For more information: www.ariahealth.org

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Overlay Init